Channels - Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist :: FRELIP Discovery

Similar Items: Population pharmacokinetics of remlifanserin (ACP‐204), a serotonin 2A receptor inverse agonist

Quick Look
Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment
Quick Look
Reduced CB1 Cannabinoid Receptor Expression in Alzheimer's Disease and Transgenic Mouse Models
Quick Look
Associations between neuronavigated rTMS‐mediated functional connectome plasticity and neurotransmitter receptors in Alzheimer's disease
Quick Look
Economic evaluations of strategies targeting pre‐diagnosis dementia populations: A systematic review
Quick Look
Postural Changes on Heart Rate Variability among Older Population: A Preliminary Study
Quick Look
Frontotemporal dementia in Hispanic populations: Regional and national comparisons
Quick Look
Heritability of Alzheimer's disease–related plasma biomarkers in the Amish population
Quick Look
Morbidity Among the Aging Population in Northern Bangladesh: An Epidemiological Study
Quick Look
Assessment of the Health Status of the Oldest Olds Living on the Greek Island of Ikaria: A Population Based-Study in a Blue Zone
Quick Look
Identifying populations with faster cognitive decline using blood‐based biomarkers
Quick Look
Validation of the Patient Health Questionnaire‐2 (PHQ‐2) in Detecting Depression Among Older Adults
Quick Look
Cerebrospinal fluid NPTX2/p‐tau ratio as a biomarker for cognitive decline in neurodegenerative diseases
Quick Look
Subsequent Hypertension’s Mediation of the Association Between Sleep Duration Trajectories and New-Onset Cardiovascular Disease: Population-Based Cohort Study
Quick Look
Person‐centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge‐2 randomized clinical trial
Quick Look
Reprogramming lipid metabolism for cognitive restoration in Alzheimer's via PLA2G4E
Quick Look
Determining the Protective Effects of Long‐Term Physical Activity, Exercise, Mental Health, and Employment on Sarcopenia—A Result of a Feasibility Study of a Registry
Quick Look
Real‐world pharmacovigilance for anti‐Aβ therapies using a large language model
Quick Look
A diagnostic plasma omics‐biomarker for Alzheimer's disease informed by microglial single‐cell transcriptomics: A pilot study
Quick Look
Variable Aβ tracer uptake in hyperostosis frontalis interna: implications for brain Aβ PET/CT interpretation
Quick Look
A Community-in-the-Loop Approach to Smart Home Monitoring for Aging in Place: Mixed Methods Evaluation of a Co-Designed Prototype
Quick Look
Physical Exercise for Healthy Older Adults and Those with Frailty: What Exercise Is Best and Is There a Difference? A Systematic Review and Meta-Analyses
Quick Look
Development of a Japanese version of the Family Stigma Instrument for dementia
Quick Look
Aβ‐ and tau‐associated neuroinflammatory signatures in Alzheimer's disease
Quick Look
Fungal Melanin as a Potential Geroprotector: First In Vitro Insights